Formulation Studies to Develop Low-Cost, Orally-Delivered Secretory IgA Monoclonal Antibodies for Passive Immunization Against Enterotoxigenic Escherichia coli-Reference-Cited by-同舟云学术

Formulation Studies to Develop Low-Cost, Orally-Delivered Secretory IgA Monoclonal Antibodies for Passive Immunization Against Enterotoxigenic Escherichia coli

Published:2023-07 Issue:7 Volume:112 Page:1832-1844
ISSN:0022-3549
Container-title:Journal of Pharmaceutical Sciences
language:en
Short-container-title:Journal of Pharmaceutical Sciences

Author:

Bajoria Sakshi^ORCID,Antunez Lorena R.^ORCID,Kumru Ozan S.^ORCID,Klempner Mark,Wang Yang,Cavacini Lisa A.^ORCID,Joshi Sangeeta B.,Volkin David B.^ORCID

Funder

Bill and Melinda Gates Foundation

Publisher

Elsevier BV

Subject

Pharmaceutical Science

Reference81 articles.

1. PATH. The case for investment in enterotoxigenic Escherichia coli vaccines. Accessed January 11, 2023. https://www.path.org/resources/the-case-for-investment-in-enterotoxigenic-escherichia-coli-vaccines/

2. Diarrhoeal disease. Accessed February 23, 2020. https://www.who.int/news-room/fact-sheets/detail/diarrhoeal-disease

3. Evans DJ, Evans DG. Escherichia coli in diarrheal disease. In: Baron S, ed. Medical Microbiology. 4th ed. University of Texas Medical Branch at Galveston; 1996. Accessed December 6, 2019. http://www.ncbi.nlm.nih.gov/books/NBK7710/

4. Secretory diarrhoea: mechanisms and emerging therapies;Thiagarajah;Nat Rev Gastroenterol Hepatol,2015

5. Zhang Y, Tan P, Zhao Y, Ma X. Enterotoxigenic Escherichia coli: intestinal pathogenesis mechanisms and colonization resistance by gut microbiota. Gut Microbes. 14(1):2055943. doi:10.1080/19490976.2022.2055943

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Stability Engineering of Recombinant Secretory IgA;International Journal of Molecular Sciences;2024-06-22